About TheraVet SA

Company Description

TheraVet is a vet biotech company headquartered in Belgium (Jumet, Wallonia) with an US-based subsidiary.

TheraVet's mission is to develop innovative, safe and effective treatments to improve the well-being and quality of life of companion animals suffering from osteoarticular diseases.

TheraVet's main targets (indications & applications) are osteoarthritis, ligament & tendon injuries and bone surgery in cats and dogs as well as horses.

TheraVet works in close collaboration with key opinion leaders in Belgium and abroad (France, Switzerland, United Kingdom & United States) to better address the ever-increasing needs of veterinary medicine.

Year founded


Served area


Shareholder information

Shares outstanding



June 17, 2021

Stock exchange(s)

Euronext Brussels



Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.